Katko Leading Bipartisan Drive to Bolster Aid for Suicide Crisis Centers

October 4, 2019 by Dan McCue

WASHINGTON – U.S. Rep. John Katko, R-N.Y., is leading a bipartisan initiative to bolster aid for suicide crisis centers.

The initiative, H.R. 4564, would amend the Public Health Service Act to ensure “the provision of high-quality service through the Suicide Prevention Lifeline.”

It is co-sponsored by Reps. Donald Beyer Jr., D-Va., and Grace Napolitano, D-Calif., and has been referred to the House Committee on Energy and Commerce.

According to a release from Katko’s office, the National Suicide Prevention Lifeline expects to receive 12 million calls over the next four years — matching the total number of calls it received over the 12-year period between 2005 and 2017.

Despite the growing demand, local crisis centers, which handle the majority of the calls, receive small stipends of just $1500 to $2500, far from enough to address callers needs.

“Crisis centers … work every day to help prevent suicide and provide counseling services for those in desperate need,” Rep. John Katko said. “But these organizations are already doing this tremendous work on a tight budget. 

“We need to support these organizations, and my bipartisan legislation does this both by bolstering funding and implementing programming to eliminate wait times, ensure those seeking assistance receive follow up, and make resources available to friends and family members of those in crisis,” he said

Specifically, the Suicide Prevention Lifeline Improvement Act:

  • Increases authorized funding for the Suicide Prevention Lifeline from $12 million to $50 million;
  • Requires HHS to develop and implement a plan to increase quality assurance, eliminate call wait times, implement evidence-based practices like follow-up, ensure resources are available to friends and family of those in crisis, create guidelines to carry out periodic testing of the Lifeline;
  • Requires increased coordination and data sharing between the Suicide Prevention Lifeline and the CDC;
  • Creates a pilot program to research and employ innovative technologies for suicide prevention;
  • Requires a study and report to Congress from both HHS and GAO on the plan implemented by HHS to reform the Lifeline as well as other recommendations for improvement to the Lifeline’s operations

“Suicide has affected far too many families in our community and nationwide – and we have tremendous work to do to combat the prevalence of suicide and reduce the stigma associated with seeking mental health care.  I remain committed to addressing this issue in Congress,” Katko said.

Mental Health

Brindisi Leads Forum on Mental Health and Addiction Issues
Mental Health
Brindisi Leads Forum on Mental Health and Addiction Issues
September 16, 2020
by Daniel Londono

WASHINGTON - Rep. Anthony Brindisi, D-N.Y., served as moderator last week at a Blue Dog Coalition forum exploring the issue of mental health and addiction in the U.S. and how to deal with it. Brindisi, the coalition's co-chair, has been an advocate for better access to... Read More

Telehealth Services Demonstrate Potential for Patient Care Amid Pandemic Constraints
Health
Telehealth Services Demonstrate Potential for Patient Care Amid Pandemic Constraints
September 8, 2020
by Reece Nations

Telehealth services have made substantial progress throughout the COVID-19 pandemic despite the hardships the health care industry as a whole has had to endure. The concept of telehealthcare is now more widely accepted than ever before. In August, a bipartisan group of lawmakers announced their support... Read More

Signs of Depression Have Tripled in US Since Pandemic Started
Research
Signs of Depression Have Tripled in US Since Pandemic Started

The COVID-19 pandemic has touched pretty much every person in America — and it shows in the state of our mental health. The prevalence of sleep troubles, lethargy, feelings of hopelessness and other depression symptoms in adults across the country has more than tripled since the... Read More

Pharma Lobby Disputes Trump’s Claim That Drug Companies Are Negotiating
Prescription Drugs
Pharma Lobby Disputes Trump’s Claim That Drug Companies Are Negotiating

WASHINGTON — The pharmaceutical industry’s leading lobby group said Tuesday it did not know of a meeting at the White House to discuss lowering prescription drug prices, after President Donald Trump said executives were coming in this week to negotiate. “We are not aware of any... Read More

How to Manage Anxiety Surrounding Back-to-School Transition
Mental Health
How to Manage Anxiety Surrounding Back-to-School Transition
August 6, 2020
by Kate Michael

WASHINGTON - Even as students across the United States are beginning to head back to class, the reopening of schools remains a topic of intense debate. While no one can predict what is ahead for the Fall of 2020, there can be no doubt that COVID-19... Read More

Cognitive Testing, Politics, and the Very Real Issue of Alzheimer's Disease and Dementia
Mental Health
Cognitive Testing, Politics, and the Very Real Issue of Alzheimer's Disease and Dementia
July 30, 2020
by Dan McCue

WASHINGTON - For weeks it had been the stuff of living room banter and fodder for self-quarantining late night comedians. Suddenly, apparently on a whim, the president who once described himself as a "very stable genius," was talking about how he "aced" a mental fitness test.... Read More

News From The Well
scroll top